Novo Nordisk AS (NVO)
110.09
-1.85
(-1.65%)
USD |
NYSE |
Nov 04, 13:00
Novo Nordisk Price to Book Value: 30.33 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 30.84 |
| October 31, 2024 | 30.84 |
| October 30, 2024 | 31.20 |
| October 29, 2024 | 30.85 |
| October 28, 2024 | 30.96 |
| October 25, 2024 | 31.24 |
| October 24, 2024 | 31.39 |
| October 23, 2024 | 31.89 |
| October 22, 2024 | 32.09 |
| October 21, 2024 | 32.33 |
| October 18, 2024 | 32.54 |
| October 17, 2024 | 32.57 |
| October 16, 2024 | 32.52 |
| October 15, 2024 | 32.46 |
| October 14, 2024 | 33.00 |
| October 11, 2024 | 33.07 |
| October 10, 2024 | 32.38 |
| October 09, 2024 | 32.24 |
| October 08, 2024 | 32.29 |
| October 07, 2024 | 32.45 |
| October 04, 2024 | 31.72 |
| October 03, 2024 | 31.71 |
| October 02, 2024 | 32.10 |
| October 01, 2024 | 32.52 |
| September 30, 2024 | 32.81 |
| Date | Value |
|---|---|
| September 27, 2024 | 33.28 |
| September 26, 2024 | 34.25 |
| September 25, 2024 | 34.98 |
| September 24, 2024 | 34.57 |
| September 23, 2024 | 34.09 |
| September 20, 2024 | 35.14 |
| September 19, 2024 | 37.17 |
| September 18, 2024 | 36.39 |
| September 17, 2024 | 36.38 |
| September 16, 2024 | 37.73 |
| September 13, 2024 | 37.76 |
| September 12, 2024 | 37.66 |
| September 11, 2024 | 37.27 |
| September 10, 2024 | 35.77 |
| September 09, 2024 | 36.35 |
| September 06, 2024 | 36.14 |
| September 05, 2024 | 36.07 |
| September 04, 2024 | 37.08 |
| September 03, 2024 | 37.55 |
| August 30, 2024 | 38.35 |
| August 29, 2024 | 37.90 |
| August 28, 2024 | 37.07 |
| August 27, 2024 | 37.26 |
| August 26, 2024 | 37.29 |
| August 23, 2024 | 37.75 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
13.44
Minimum
Mar 20 2020
45.73
Maximum
Jun 25 2024
25.05
Average
23.73
Median
Oct 24 2022
Price to Book Value Benchmarks
| Evaxion Biotech AS | 11.53 |
| Amgen Inc | 22.61 |
| Viking Therapeutics Inc | 8.299 |
| Adaptimmune Therapeutics PLC | 2.214 |
| Genfit SA | 2.907 |
Price to Book Value Related Metrics
| PE Ratio | 37.78 |
| PS Ratio | 13.16 |
| PEG Ratio | 0.9867 |
| Price to Free Cash Flow | 51.83 |
| Price | 110.09 |
| Earnings Yield | 2.65% |
| Market Cap | 489.91B |
| PEGY Ratio | 0.9546 |
| Operating PE Ratio | 30.46 |
| Normalized PE Ratio | 37.78 |